These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22007842)

  • 21. Physicians prescribing "medicine" for enhancement: Why we should not and cannot overlook safety concerns.
    Drabiak-Syed K
    Am J Bioeth; 2011 Jan; 11(1):17-9. PubMed ID: 21240799
    [No Abstract]   [Full Text] [Related]  

  • 22. Cosmetic neurology: the controversy over enhancing movement, mentation, and mood.
    Chatterjee A
    Neurology; 2004 Sep; 63(6):968-74. PubMed ID: 15452285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examining reports and policies on cognitive enhancement: approaches, rationale, and recommendations.
    Outram SM; Racine E
    Account Res; 2011; 18(5):323-41. PubMed ID: 21916740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managed care and neurologists: ethical considerations. The Ethics and Humanities Subcommittee of the Practice Committee of the American Academy of Neurology.
    Neurology; 1997 Aug; 49(2):321-2. PubMed ID: 9270556
    [No Abstract]   [Full Text] [Related]  

  • 25. Cognition-enhancing drugs.
    Mehlman MJ
    Milbank Q; 2004; 82(3):483-506, table of contents. PubMed ID: 15330974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public Views on Whether the Use of Pharmaceutical Neuroenhancements Should Be Allowed.
    Hendriks S; Li X; Grady C; Kim SY
    Neurology; 2024 Aug; 103(4):e209681. PubMed ID: 39042847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors influencing the prescribing of nootropic drugs. Results of a representative inquiry in Lower Saxony].
    Stoppe G; Sandholzer H; Staedt J; Kiefer J; Winter S; Kochen MM; Rüther E
    Dtsch Med Wochenschr; 1995 Nov; 120(47):1614-9. PubMed ID: 7493562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical research into cognition enhancers.
    Sarter M
    Trends Pharmacol Sci; 2006 Nov; 27(11):602-8. PubMed ID: 16997388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive enhancement: methods, ethics, regulatory challenges.
    Bostrom N; Sandberg A
    Sci Eng Ethics; 2009 Sep; 15(3):311-41. PubMed ID: 19543814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The is and ought of the Ethics of Neuroenhancement: Mind the Gap.
    Forlini C; Hall W
    Front Psychol; 2015; 6():1998. PubMed ID: 26779100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to open peer commentaries on "'Doctor, would you prescribe a pill to help me … ?' a national survey of physicians on using medicine for human enhancement".
    Hotze TD; Shah K; Anderson EE; Wynia MK
    Am J Bioeth; 2011 Jan; 11(1):W1-3. PubMed ID: 21240794
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of methylphenidate among students: the future of enhancement?
    Outram SM
    J Med Ethics; 2010 Apr; 36(4):198-202. PubMed ID: 20338928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroenhancement: enhancing brain and mind in health and in disease.
    Clark VP; Parasuraman R
    Neuroimage; 2014 Jan; 85 Pt 3():889-94. PubMed ID: 24036352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroethical theories.
    Häyry M
    Camb Q Healthc Ethics; 2010 Apr; 19(2):165-78. PubMed ID: 20226100
    [No Abstract]   [Full Text] [Related]  

  • 36. Accelerating human evolution.
    Harris ED
    Pharos Alpha Omega Alpha Honor Med Soc; 2009; 72(3):1. PubMed ID: 19722297
    [No Abstract]   [Full Text] [Related]  

  • 37. Policy must recognize drug impact on different sectors.
    Pierce R; Illes J
    Nature; 2008 Jan; 451(7178):521. PubMed ID: 18235479
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuroenhancement: State of the Art and Future Perspectives.
    Marazziti D; Avella MT; Ivaldi T; Palermo S; Massa L; Vecchia AD; Basile L; Mucci F
    Clin Neuropsychiatry; 2021 Jun; 18(3):137-169. PubMed ID: 34909030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'Smart drugs': do they work? Are they ethical? Will they be legal?
    Rose SP
    Nat Rev Neurosci; 2002 Dec; 3(12):975-9. PubMed ID: 12461554
    [No Abstract]   [Full Text] [Related]  

  • 40. Reasons for prescribing cognition enhancers in primary care. Results of a representative survey in Lower Saxony, Germany.
    Stoppe G; Sandholzer H; Staedt J; Winter S; Kiefer J; Rüther E
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):486-90. PubMed ID: 8520805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.